Skip to main content

Table 2 Clinical response to primary chemotherapy and breast cancer outcome

From: Glutathione S-transferase M1 null genotype: lack of association with tumour characteristics and survival in advanced breast cancer

 

GSTM1

 

Parameters

Present

Null

P

Objective response*

76.9%

75.5%

0.8719

Disease-free survival (months)

42.00 ± 2.65

54.43 ± 5.67

0.8094

Overall survival (months)

74.82 ± 3.95

72.73 ± 4.81

0.9729

  1. *Objective response was estimated as complete and partial responses. Estimated by Pearson χ2 test. Estimated by log rank test, median± standard error. GST, glutathione S-transferase.